Fundraising Fox
🦊/Companies
Sign in

Modifi Biosciences

New Haven, US · Founded 2021 · Delaware corporation · 9 known investors

Find your way into Modifi Biosciences

291 people in our graph share verified history with the Modifi Biosciences team — schools, employers, funds. One of them is your warm intro.

Anthony Philippakisunlockedknows Ranjit Bindra · together at Yale University (overlapped)
×3knows the team · via Yale School of Medicine
×4knows the team · via Yale University
knows the team · via Modifi Bio
×2knows the team · via MSKCC
knows the team · via Ey

Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines. It provides information for patients, investors, and communities and highlights its drug pipeline and clinical trials.

BiotechHealthtech

Founders & leadership

Modifi Biosciences was founded in 2021 by Ranjit Bindra and Kingson Lin.

RBRanjit Bindra
Ranjit BindrainCo-founderOperating Partner at HighCape Capital
KLKingson Lin
Kingson LininCofounder30 Under 30 2024
KLKevin L. Rakin
Kevin L. RakininExecutiveKevin L. Rakin is co-founder of HighCape Capital, a growth equity firm focused on life sciences companies, and has over 30 years of experience as an investor and executive in the industry. He previously served as CEO of Advanced BioHealing (acquired by Shire for $750M in 2011) and co-founded Genaissance Pharmaceuticals, a publicly traded pharmacogenomics company.

Board

LD
Lucas de BreedBoard director
KK
Kat Kayser-BrickerBoard director

Investors · 9

Connecticut InnovationsNew Haven · $500K – $2M
HighCape CapitalWestport
Pathway BioventuresChicago
Ironwood Capitalreported · 2 sourcesAvon

Also in the syndicate · 5

Advantage Capital (Ironwood)BrightEdgeConnecticut InnovationNational Brain Tumor SocietyThe Sontag Foundation

Funding

SEC filings, press & company announcements

$15.8M disclosed across 3 rounds · 2022–2024

▶$995.5KraisedAug 2024 · 39 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kat Kayser-BrickerDirector
  • Kevin L. RakinExecutive Officer, Director
  • Lucas de BreedDirector
  • Ranjit BindraDirector
Offering amount
$1M
Amount sold
$995.5K
First sale
Aug 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.5MraisedAug 2023 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin L. RakinExecutive Officer, Director
  • Ranjit BindraDirector
  • Lucas de BreedDirector
  • Kat Kayser-BrickerDirector
Offering amount
$11.4M
Amount sold
$10.5M
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Modifi Bio: $4.3 Million In Seed Funding Secured To Target Cancer Using DNA Modificationpulse2.com · Oct 2023Modifi Bio Raises Additional $4.3 Million in Seed Funding - BioSpacebiospace.com · Oct 2023A lab-to-market plan for Modifi Biosciences | Department of Chemistrychem.yale.edu · Nov 2022Yale spinout Modifi Bio announces seed fundinghartfordbusiness.com · Jul 2022

Frequently asked questions

What does Modifi Biosciences do?
Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines. It provides information for patients, investors, and communities and highlights its drug pipeline and clinical trials.
Who founded Modifi Biosciences?
Modifi Biosciences was founded by Ranjit Bindra, Kingson Lin in 2021.
Who are Modifi Biosciences's investors?
Modifi Biosciences's investors include Connecticut Innovations, HighCape Capital, Pathway Bioventures, Ironwood Capital.
How much funding has Modifi Biosciences raised?
Modifi Biosciences has disclosed $15.8M raised across 3 rounds.
Where is Modifi Biosciences headquartered?
Modifi Biosciences is headquartered in New Haven, US.